1-2 of 2
Miguel Izquierdo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study

Clinical Trials & Observations
Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Hiroaki Goto, Hyoung Jin Kang, Terri Guinipero, Zeynep Karakas, Francisco Bautista, Stéphane Ducassou, Keon Hee Yoo, Christian Michel Zwaan, Frédéric Millot, Briana C. Patterson, Jill Samis, Miguel Izquierdo, Ksenia Titorenko, Sai Li, Darintr Sosothikul
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7279–7289.
https://doi.org/10.1182/bloodadvances.2023010122
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy

Clinical Trials & Observations
David G. Maloney, Michinori Ogura, Noriko Fukuhara, Jaclyn Davis, Janet Lasher, Miguel Izquierdo, Hiya Banerjee, Kensei Tobinai
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3886–3893.
https://doi.org/10.1182/bloodadvances.2020001942
Published: 2020